Tags

Type your tag names separated by a space and hit enter

Update on influenza A (H1N1) 2009 monovalent vaccines.
MMWR Morb Mortal Wkly Rep. 2009 Oct 09; 58(39):1100-1.MM

Abstract

On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza A (H1N1) virus. Both live, attenuated and inactivated influenza A (H1N1) 2009 monovalent vaccine formulations are available; each contains the strain A/California/7/2009(H1N1)pdm. None of the approved influenza A 2009 (H1N1) monovalent vaccines or seasonal influenza vaccines contains adjuvants. CDC's Advisory Committee on Immunization Practices has made recommendations previously for which persons should be the initial targets for immunization with influenza A (H1N1) 2009 monovalent vaccines and has issued guidelines on decisions for expansion of vaccination efforts to other population groups. Children aged 6 months--9 years receiving influenza A (H1N1) 2009 monovalent vaccines should receive 2 doses, with doses separated by approximately 4 weeks; persons aged >or=10 years should receive 1 dose.

Authors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19816398

Citation

Centers for Disease Control and Prevention (CDC). "Update On Influenza a (H1N1) 2009 Monovalent Vaccines." MMWR. Morbidity and Mortality Weekly Report, vol. 58, no. 39, 2009, pp. 1100-1.
Centers for Disease Control and Prevention (CDC). Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb Mortal Wkly Rep. 2009;58(39):1100-1.
Centers for Disease Control and Prevention (CDC). (2009). Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR. Morbidity and Mortality Weekly Report, 58(39), 1100-1.
Centers for Disease Control and Prevention (CDC). Update On Influenza a (H1N1) 2009 Monovalent Vaccines. MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1. PubMed PMID: 19816398.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on influenza A (H1N1) 2009 monovalent vaccines. A1 - ,, PY - 2009/10/10/entrez PY - 2009/10/10/pubmed PY - 2009/10/15/medline SP - 1100 EP - 1 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 58 IS - 39 N2 - On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza A (H1N1) virus. Both live, attenuated and inactivated influenza A (H1N1) 2009 monovalent vaccine formulations are available; each contains the strain A/California/7/2009(H1N1)pdm. None of the approved influenza A 2009 (H1N1) monovalent vaccines or seasonal influenza vaccines contains adjuvants. CDC's Advisory Committee on Immunization Practices has made recommendations previously for which persons should be the initial targets for immunization with influenza A (H1N1) 2009 monovalent vaccines and has issued guidelines on decisions for expansion of vaccination efforts to other population groups. Children aged 6 months--9 years receiving influenza A (H1N1) 2009 monovalent vaccines should receive 2 doses, with doses separated by approximately 4 weeks; persons aged >or=10 years should receive 1 dose. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/19816398/Update_on_influenza_A__H1N1__2009_monovalent_vaccines_ L2 - https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5839a3.htm DB - PRIME DP - Unbound Medicine ER -